Relook TURBT in superficial bladder cancer: Its importance and its correlation with the tumor ploidy

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 5, 2009, Pages 514-519

  Dwivedi, Udai S ^a   Kumar, Abhay ^a   Das, Suren K ^a   Trivedi, Sameer ^a   Kumar, Mohan ^a   Sunder, Shyam ^a   Singh, Pratap B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Flow cytometry; Ploidy; Relook TURBT; Superficial bladder cancer

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; TRANSURETHRAL RESECTION OF BLADDER TUMOR; TUMOR VOLUME;

AGED; CYSTECTOMY; FLOW CYTOMETRY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PLOIDIES; PROGNOSIS; URINARY BLADDER NEOPLASMS;

EID: 69249133454     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2008.04.015     Document Type: Article

References (26)

1. Malmstrom P.U., Busch C., and Norlen B.J. Recurrence, progression, and survival in bladder cancer. Scand J Urol Nephrol 21 (1987) 185-195
2. Konety B.R., and Williams R.D. Superficial transitional (Ta/T1/CIS) cell carcinoma of the bladder. BJU Int 94 (2004) 18-21
3. Schwaibold H.E., Silvalingam S., May F., et al. The value of a second transurethral resection for T1 bladder cancer. BJU Int 97 (2006) 1199-1201
4. Kohrmann K.U., Woeste M., Kappes J., et al. Der West dee transurethralen Nachresektion beim oberflachlichen harnblasenkarzinom. Akta Urol 25 (1994) 208-211
5. Klan R., Loy V., and Huland H. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol 146 (1991) 316-318
6. Vogeli T.A., Thiel R., Grimm M., et al. Does urine cytology contribute to decision making for reTUR of transitional cell carcinoma of the bladder?. J Urol 157 Suppl (1997) A1479
7. Herr H.W. The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162 (1999) 74-76
8. Dutta S.C., Smith Jr. J.A., Shappell S.B., et al. Clinical understaging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. J Urol 166 (2001) 490-493
9. Brausi M., Collette L., Kurth K., et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol 41 (2002) 523-527
10. Zurkirchen M.A., Sulses T., Gaspert A., et al. Second transurethral resection of superficial transitional cell carcinoma of the bladder: A must even for experienced urologist. Urol Int 72 (2004) 99-102
11. Kriegmair M., Zaak D., Rothenberger K.H., et al. Transurethral resection for bladder cancer using 5-aminolevulinic acid induced fluorescence endoscopy versus white light endoscopy. J Urol 168 (2002) 475-478
12. Divrik T., Yildirim U., Eroglu A., et al. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?. J Urol 175 (2006) 1258-1261
13. Manoharan M. Optimal management of T1G3 bladder cancer. Urol Clin N Am 32 (2005) 133-145
14. May M., Nitzke T., Helka C., et al. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 38 (2004) 231-235
15. Grimm M.O., Steinhoff C., Simon X., et al. Effect of routine repeat transurethral resection of superficial bladder cancer: A long term observational study. J Urol 170 (2003) 433-437
16. Divrik R.T., Yildirim U., Zorle F., et al. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumor of the bladder who received intravesical Mitomycin: A prospective, randomized clinical trial. J Urol 175 (2005) 1641-1644
17. Herr H.W. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174 (2005) 2134-2137
18. Rubben H., Lutzeyer W., Ficher N., et al. Natural history and treatment of low and high risk superficial bladder tumors. J Urol 139 (1988) 283-285
19. Millan-Rodriguez F., Chechile-Toniolo G., Salvador-Bayarri J., et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 163 (2000) 73-78
20. Narayana A.S., Leoning S.A., Slymen D.J., et al. Bladder cancer factors affecting survival. J Urol 130 (1983) 56-60
21. Dalesio O., Schulman C., Sylvester R., et al. Prognostic factors in superficial bladder tumors. A study of the European organization for research on treatment of cancer: Genitourinary Tract cancer cooperation Group. J Urol 129 (1983) 730-734
22. Cai T., Margallo E., Nesi G., et al. Prognostic value of static cytometry in transitional cell carcinoma of the bladder recurrence rate and survival in a group of patients at 10 years follow up. Oncol Rep 15 (2006) 213-219
23. Falkman K., Tribukait B., Nyman C.R., et al. S-phase fraction in superficial urothelial carcinoma of the bladder-a prospective, long term, follow-up study. Scand J Urol Nephrol 38 (2004) 278-284
24. Grafors T., Duchek M., Tomic R., et al. Predictive value of DNA ploidy in bladder cancer treated with preoperative radiation therapy and cystectomy. Scand J Urol Nephrol 30 (1996) 281-285
25. Desgrippes A., Padifar V., Assailly T., et al. Diagnosis and prediction of recurrence and progression in superficial bladder cancers with DNA image cytometry and urinary cytology. BJU Int 85 (2000) 434-436
26. Sylvester R.J., van der Meijden A.P., Oosterlinck W., et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2,596 patients from seven EORTC trials. Eur Urol 49 (2006) 466